Antibody-Mediated Inhibition of TNFR1 Attenuates Disease in a Mouse Model of Multiple Sclerosis

• Sarah K. Williams ,

  * E-mail: s.williams@dkfz-heidelberg.de

  Affiliation Department of Neuro-oncology, University Clinic Heidelberg, Heidelberg, Germany

  ⨯
• Olaf Maier,

  Affiliation Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany

  ⨯
• Roman Fischer,

  Affiliation Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany

  ⨯
• Richard Fairless,

  Affiliation Department of Neuro-oncology, University Clinic Heidelberg, Heidelberg, Germany

  ⨯
• Sonja Hochmeister,

  Affiliation Department of Neurology, Medical University of Graz, Graz, Austria

  ⨯
• Aleksandar Stojic,

  Affiliation Department of Neuro-oncology, University Clinic Heidelberg, Heidelberg, Germany

  ⨯
• Lara Pick,

  Affiliation Department of Neurology, University of the Saarland, Homburg/Saar, Germany

  ⨯
• Doreen Haar,

  Affiliation Department of Neurology, University of the Saarland, Homburg/Saar, Germany

  ⨯
• Sylvia Musiol,

  Affiliation Department of Neurology, University of the Saarland, Homburg/Saar, Germany

  ⨯
• Maria K. Storch,

  Affiliation Department of Neurology, Medical University of Graz, Graz, Austria

  ⨯
• Klaus Pfizenmaier,

  Affiliation Institute of Cell Biology and Immunology, University of Stuttgart, Stuttgart, Germany

  ⨯
• Ricarda Diem

  Affiliation Department of Neuro-oncology, University Clinic Heidelberg, Heidelberg, Germany

  ⨯